Baseline demographics across each stage of CKD
CKD stage?2 n=14 | CKD Stage?3 n=17 | CKD Stage?4 n=9 | CKD Stage?5 n=21 | P Value | |
|---|---|---|---|---|---|
Age (years) | 59 (45–67) | 65 (54–67) | 57 (53–69) | 46 (33–58) | 0.14 |
Male | 8 (57%) | 10 (59%) | 6 (67%) | 11 (55%) | 0.912 |
Hg (g/L) | 134±38 | 135±11 | 130±15 | 107±47 | 0.003 |
NT-pro BNP | 68±70 | 156±152 | 189±115 | 631±651 | 0.001 |
EF (%) | 71±7 | 70±6 | 68±10 | 69±9 | 0.913 |
LVMi (g/m2) | 62±13 | 60±15 | 62±9 | 84±38 | 0.01 |
% Predicted VO2 at Peak | 84 (77–109) | 86 (82–94) | 80 (73–88) | 73 (62–91) | 0.019 |
% Predicted VO2 at AT | 55 (42–69) | 61 (55–66) | 49 (41–56) | 46 (39–60) | 0.023 |
RER | 1.19±0.05 | 1.17±0.11 | 1.18±0.08 | 1.18±0.12 | 0.915 |
Resting global longitudinal strain (%) | −18.8±2.1 | −18.0±2.4 | −17.9±1.9 | −19.5±3.1 | 0.320 |
Data are presented as median an interquartile range, or mean and standard deviation. A p value of <0.05 demonstrates significance at the 95% confidence interval using the Kruskall Wallis test.